Metraipolis › archive › dc_4e76412eab8c

Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot study — Europe PMC PMID:41102719

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41102719
DOI
10.1186/s12885-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-09T06:12:00.848Z
SHA-256 of the archived text
7b5f77403a99ae264fd787ac902dac48524ad4c1a57c3c90721fecbfb4451c4c
Stable URL of this page
https://metraipolis.com/documento/dc_4e76412eab8c

How to cite

Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot study — Europe PMC PMID:41102719 — Europe PMC (en), https://europepmc.org/article/MED/41102719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e76412eab8c (Metraipolis archive dc_4e76412eab8c, sha256 7b5f77403a99ae264fd787ac902dac48524ad4c1a57c3c90721fecbfb4451c4c)
BibTeX
@misc{dc4e76412eab8c,
  title = {Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot study — Europe PMC PMID:41102719},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41102719},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e76412eab8c; sha256 7b5f77403a99ae264fd787ac902dac48524ad4c1a57c3c90721fecbfb4451c4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41102719. Agents can read the archived copy with the MCP tool read_document.